
Evaluation of confirmatory data following the Article 12 MRL review for pyraclostrobin
Author(s) -
Brancato Alba,
Brocca Daniela,
Carrasco Cabrera Luis,
De Lentdecker Chloe,
Erdos Zoltan,
Ferreira Lucien,
Greco Luna,
Jarrah Samira,
Kardassi Dimitra,
Leuschner Renata,
Lostia Alfonso,
Lythgo Christopher,
Medina Paula,
Miron Ileana,
Molnar Tunde,
Pedersen Ragnor,
Reich Hermine,
Sacchi Angela,
Santos Miguel,
Stanek Alois,
Sturma Juergen,
Tarazona Jose,
Theobald Anne,
Vagenende Benedicte,
VillamarBouza Laura
Publication year - 2018
Publication title -
efsa journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.076
H-Index - 97
ISSN - 1831-4732
DOI - 10.2903/j.efsa.2018.5472
Subject(s) - member states , table (database) , business , medicine , microbiology and biotechnology , environmental health , european union , political science , computer science , database , biology , international trade
The applicant BASF SE submitted a request to the competent national authority in Germany to evaluate the confirmatory data that were identified for pyraclostrobin in the framework of the MRL review under Article 12 of Regulation ( EC ) No 396/2005 as not available. To address the data gaps, residues trials supporting the existing use of pyraclostrobin on table grapes authorised in southern EU Member States and an analytical method for analysing residues of pyraclostrobin in coffee beans were submitted. The data gap for coffee beans was considered satisfactorily addressed. The new residue trials in table grapes give an indication that the existing MRL for table grapes should be raised. However, since a potential acute consumer health risk for table grapes could not be excluded, EFSA recommend the lowering of the existing MRL .